2024
Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial
Krumholz H, de Lemos J, Sattar N, Linetzky B, Sharma P, Mast C, Ahmad N, Bunck M, Stefanski A. Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial. Heart 2024, 110: 1165-1171. PMID: 39084707, PMCID: PMC11420724, DOI: 10.1136/heartjnl-2024-324170.Peer-Reviewed Original ResearchBlood pressure reductionBlood pressure subgroupBlood pressurePost hoc analysisPressure reductionTirzepatide groupsAdverse eventsDiastolic blood pressure reductionHoc analysisAssociated with reduced blood pressureEffects of tirzepatideWeight-related complicationsOverall blood pressureLower blood pressure levelsWeight lossNormal blood pressureDiastolic blood pressureLower blood pressureBlood pressure levelsRandomised controlled trialsMediation analysisTirzepatideClinical subgroupsControlled hypertensionPlacebo
2022
Racial and Ethnic Disparities in Financial Barriers Among Overweight and Obese Adults Eligible for Semaglutide in the United States
Lu Y, Liu Y, Krumholz HM. Racial and Ethnic Disparities in Financial Barriers Among Overweight and Obese Adults Eligible for Semaglutide in the United States. Journal Of The American Heart Association 2022, 11: e025545. PMID: 36172953, PMCID: PMC9673703, DOI: 10.1161/jaha.121.025545.Peer-Reviewed Original ResearchConceptsLow family incomeEligible populationUsual sourceHispanic adultsFinancial barriersEthnic disparitiesNutrition Examination Survey 2015Drug Administration labelingCross-sectional analysisFamily incomePercentage of adultsObese adultsNational HealthUS adultsSemaglutideEligibility criteriaSocial determinantsBlack adultsLarge proportionFinal analysisWeight lossHispanic individualsWhite individualsAdultsRisk reduction
2007
Predictors of weight change in overweight patients with myocardial infarction
Fadl YY, Krumholz HM, Kosiborod M, Masoudi FA, Peterson PN, Reid KJ, Weintraub WS, Buchanan DM, Spertus JA. Predictors of weight change in overweight patients with myocardial infarction. American Heart Journal 2007, 154: 711-717. PMID: 17892997, DOI: 10.1016/j.ahj.2007.06.006.Peer-Reviewed Original ResearchConceptsPost-MI patientsMyocardial infarctionOverweight patientsWeight changeWeight lossDepression 1 monthMean weight changePercent weight changeMultivariable linear regressionBaseline obesityOverweight survivorsMorbid obesityObese patientsProspective cohortMultivariable analysisIndependent correlatesWeight managementLifestyle characteristicsPatientsMean increasePREMIER studyHealth insuranceMonthsOverweightInfarction
2003
Efficacy and Safety of Low-Carbohydrate Diets: A Systematic Review
Bravata DM, Sanders L, Huang J, Krumholz HM, Olkin I, Gardner CD, Bravata DM. Efficacy and Safety of Low-Carbohydrate Diets: A Systematic Review. JAMA 2003, 289: 1837-1850. PMID: 12684364, DOI: 10.1001/jama.289.14.1837.Peer-Reviewed Original ResearchConceptsLow-carbohydrate dietSerum insulin levelsDiet durationSerum lipidsBlood pressureInsulin levelsSerum glucoseWeight lossAge 50 yearsParticipant weight lossLonger diet durationEnglish-language studiesSignificant adverse effectsObese patientsDietary interventionMean ageOutpatient settingCaloric intakeInclusion criteriaTotal caloriesAbstraction formCalorie intakeInsufficient evidenceSystematic reviewOutpatient recipients